JONATHAN SLONIN - 02 Jan 2026 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Chief Medical Officer
Signature
/s/ Kristen Williams, Attorney-in-Fact
Issuer symbol
PCRX
Transactions as of
02 Jan 2026
Net transactions value
-$9,319
Form type
4
Filing time
06 Jan 2026, 17:30:54 UTC
Previous filing
19 Nov 2025
Next filing
03 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
SLONIN JONATHAN Chief Medical Officer C/O PACIRA BIOSCIENCES, INC., 2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE /s/ Kristen Williams, Attorney-in-Fact 06 Jan 2026 0001875723

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Tax liability $9,319 -381 -0.21% $24.46 178,523 02 Jan 2026 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award.
F2 Includes 537.166 shares of common stock acquired under the issuer's employee stock purchase plan in December 2025.